SecSonar.com

ICON Public Limited Company (ICLR)

ICON Public Limited Company at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

ICON Public Limited Company (ICLR) is a Medical - Diagnostics & Research company based in IE with a market capitalization of $10.5B. Revenue declined 0.4% year-over-year and the company generated $862M in free cash flow. This page tracks ICLR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IE · 41.25K employees · IPO May 15, 1998

Valuation

Valuation & price

$113.82 · as of May 26, 2026 · -43.9% vs 52w high

39.2

P/E ratio

Latest-FY diluted EPS

1.15

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$201$147$93.00Jul 25Dec 25Jul 26Jul 7, 25$147.59Jul 9, 25$150.53Jul 11, 25$150.52Jul 15, 25$145.58Jul 17, 25$146.88Jul 21, 25$139.63Jul 23, 25$167.89Jul 25, 25$187.01Jul 29, 25$185.21Jul 31, 25$169.19Aug 4, 25$164.80Aug 6, 25$155.42Aug 11, 25$159.71Aug 13, 25$176.29Aug 15, 25$175.84Aug 19, 25$179.64Aug 21, 25$175.70Aug 25, 25$171.75Aug 27, 25$174.00Aug 29, 25$177.94Sep 3, 25$180.01Sep 5, 25$174.88Sep 9, 25$168.94Sep 11, 25$175.11Sep 16, 25$173.13Sep 18, 25$179.43Sep 22, 25$170.80Sep 24, 25$167.49Sep 26, 25$163.79Sep 30, 25$175.00Oct 2, 25$192.96Oct 6, 25$190.43Oct 8, 25$186.48Oct 10, 25$183.49Oct 14, 25$185.91Oct 16, 25$188.46Oct 21, 25$193.26Oct 23, 25$180.00Oct 27, 25$182.03Oct 29, 25$165.95Oct 31, 25$171.82Nov 4, 25$162.96Nov 6, 25$160.00Nov 10, 25$157.68Nov 12, 25$163.42Nov 14, 25$162.18Nov 18, 25$161.02Nov 20, 25$158.12Nov 25, 25$174.53Nov 28, 25$185.00Dec 2, 25$183.14Dec 4, 25$185.77Dec 8, 25$182.10Dec 10, 25$185.86Dec 12, 25$186.58Dec 16, 25$182.45Dec 18, 25$178.70Dec 22, 25$179.14Dec 24, 25$183.68Dec 29, 25$182.36Jan 2, 26$188.67Jan 6, 26$201.48Jan 8, 26$188.22Jan 12, 26$180.15Jan 14, 26$184.77Jan 16, 26$182.61Jan 21, 26$184.87Jan 23, 26$186.70Jan 27, 26$187.97Jan 29, 26$185.89Feb 2, 26$178.59Feb 4, 26$163.11Feb 9, 26$154.57Feb 11, 26$133.14Feb 13, 26$93.00Feb 18, 26$96.50Feb 20, 26$99.70Feb 24, 26$104.09Feb 26, 26$106.13Mar 2, 26$108.27Mar 4, 26$110.20Mar 6, 26$107.20Mar 10, 26$106.62Mar 12, 26$97.45Mar 17, 26$100.49Mar 19, 26$98.05Mar 23, 26$100.35Mar 25, 26$99.99Mar 27, 26$102.08Mar 31, 26$110.66Apr 2, 26$114.19Apr 7, 26$107.16Apr 9, 26$106.70Apr 13, 26$110.37Apr 15, 26$116.50Apr 17, 26$119.68Apr 22, 26$115.43Apr 24, 26$102.17Apr 28, 26$102.49Apr 30, 26$118.33May 4, 26$111.97May 6, 26$124.13May 8, 26$124.49May 12, 26$121.94May 14, 26$117.09May 18, 26$113.78May 20, 26$115.09May 22, 26$116.78May 28, 26$136.80Jun 1, 26$138.03Jun 3, 26$143.90Jun 5, 26$149.45Jun 9, 26$151.82Jun 11, 26$149.92Jun 15, 26$147.72Jun 17, 26$143.27Jun 22, 26$140.73Jun 24, 26$158.17Jun 26, 26$169.86Jul 2, 26$173.06
$80.0852-week range$202.92
Loading valuation history…

Fundamentals

Key fundamentals

$10.5B

Market cap

-0.4%

Revenue growth (YoY)

26.4%

Gross margin

$862M

Free cash flow (USD)

$2.9B

Net debt

-4.9%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.7BFY 2017$1.8BFY 2018$2.6BFY 2019$2.8BFY 2020$2.8BFY 2021$5.5BFY 2022$7.7BFY 2023$8.1BFY 2024$8.3BFY 2025$8.3B
$1.7B$8.3B

Free cash flow by year

2016 → 2025

FY 2016$216.6MFY 2017$48.7MFY 2018$215.6MFY 2019$361.9MFY 2020$543.7MFY 2021$735.4MFY 2022$421.2MFY 2023$1.0BFY 2024$1.1BFY 2025$862.0M
$216.6M$862M

Gross margin by year

2021 → 2025

FY 202127.5%FY 202228.6%FY 202329.6%FY 202429.4%FY 202526.4%
27.5%26.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: Jun 23, 2026 (EPS $2.50)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Annual reportAnnual Report FiledJun 26, 2026Filing
  • Quarterly reportQuarterly Report FiledJun 23, 2026Filing
  • Annual reportAnnual Report FiledJun 23, 2026Filing
  • Annual reportAnnual Report FiledJun 17, 2026Filing
  • Quarterly reportQuarterly Report FiledMay 27, 2026Filing
  • Annual reportAnnual Report FiledMay 27, 2026Filing
  • Annual report20-F FiledMay 27, 2026Filing
  • Annual reportAnnual Report FiledMay 26, 2026Filing
  • Annual reportAnnual Report FiledApr 29, 2026Filing

Questions

Frequently asked questions

What is ICON Public Limited Company's market cap?

ICON Public Limited Company (ICLR) has a market capitalization of $10.5B.

What is ICLR's P/E ratio?

ICLR trades at a price-to-earnings ratio of 39.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ICLR's price-to-book (P/B) ratio?

ICLR trades at 1.15 times book value per share.

When did ICON Public Limited Company last report earnings?

ICLR last reported earnings on June 23, 2026; the next date is not yet scheduled.

Are insiders buying ICLR stock?

SEC Form 4 filings show no open-market insider buys at ICON Public Limited Company in the last 90 days (0 sells).

Same arena

Related companies in Medical - Diagnostics & Research

RVTY

Revvity, Inc.

$11.6B

CRL

Charles River Laboratories International, Inc.

$8.9B

MEDP

Medpace Holdings, Inc.

$12.9B

QGEN

Qiagen N.V.

$7.6B

SHC

Sotera Health Company

$4.5B

RDNT

RadNet, Inc.

$4.4B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.